Isolation of a recombination-deficient mutant of Streptococcus lactis ML3.

Journal of Bacteriology
D G Anderson, L L McKay

Abstract

A recombination-deficient mutant of Streptococcus lactis ML3 designated MMS36 was isolated on the basis of its sensitivity to methyl methanesulfonate. This mutant also displayed sensitivity to UV irradiation. The inability of MMS36 to mediate homologous recombination was demonstrated by transduction of plasmid-linked lactose fermenting ability but not chromosomally mediated streptomycin resistance.

References

Jun 7, 1979·Molecular & General Genetics : MGG·P M KlapwijkR A Schilperoort
Feb 1, 1975·Journal of Bacteriology·B E Moseley, H J Copland
Apr 1, 1973·Applied Microbiology·L L McKay, K A Baldwin
Sep 1, 1973·Journal of Bacteriology·L L McKayK A Baldwin
Jan 1, 1973·Annual Review of Genetics·A J Clark
Dec 1, 1972·Journal of Bacteriology·M InoueS Mitsuhashi
Aug 1, 1980·Journal of Bacteriology·Y Yagi, D B Clewell
Aug 1, 1978·Applied and Environmental Microbiology·L L McKay, K A Baldwin

❮ Previous
Next ❯

Citations

May 5, 2005·Applied and Environmental Microbiology·Yuqing ChenGary M Dunny
Feb 1, 1984·Applied and Environmental Microbiology·D G Anderson, L L McKay
Feb 1, 1991·Biochimie·Y AuffrayP Boutibonnes
Oct 27, 1997·Journal of Bacteriology·D A MillsG M Dunny

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.